Literature DB >> 25111083

Influence of hepatitis C virus coinfection on CD4⁺ T cells of HIV-infected patients receiving HAART.

Konstantin V Shmagel1, Evgeniya V Saidakova, Larisa B Korolevskaya, Nadezhda G Shmagel, Valeriy A Chereshnev, Donald D Anthony, Michael M Lederman.   

Abstract

OBJECTIVE: The effects of hepatitis C virus (HCV) coinfection on immune homeostasis and immune restoration in treated HIV infection are not well understood.
METHODS: We studied 79 HIV-infected patients who had been receiving HAART for more than 2 years and who had HIV viral load below 50 copies/ml. Four patient groups were studied: HIV/HCV, CD4⁺ cells above 350/μl; HIV/HCV, CD4 cells below 350/μl; HIV/HCV, CD4 cells above 350/μl; HIV/HCV, CD4⁺ cells below 350/μl. Controls comprised 20 healthy volunteers. Naive, central memory, effector memory, and terminal effector CD4⁺ T cells were enumerated. Naive CD4CD31 T cells were counted as recent thymic emigrants (RTEs). Activation state and ex-vivo apoptosis of CD4⁺ T cells, levels of liver enzymes, and aspartate aminotransferase-to-platelet ratio index were evaluated.
RESULTS: CD4⁺ T-cell counts and the numbers of all circulating CD4 T-cell maturation subsets were diminished in HIV infection; CD4⁺ T-cell activation and apoptosis were increased in HIV infection, but none of these indices was affected by HCV coinfection. RTE numbers were diminished in HIV infection, were inversely related to age, and were increased in women and lower in HIV/HCV patients than in singly HIV-infected patients. In coinfected patients, RTE numbers were inversely related to levels of liver enzymes, but not to HCV viral load.
CONCLUSION: Whereas we could find no relationship between HCV infection and most indices of CD4⁺ T-cell homeostasis or activation, CD4⁺ RTEs are diminished in the circulation of HCV coinfected persons and appear to be related to indices of ongoing hepatic damage or inflammation. 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25111083     DOI: 10.1097/QAD.0000000000000418

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  12 in total

1.  Differences in Response to Antiretroviral Therapy by Sex and Hepatitis C Infection Status.

Authors:  Julia L Marcus; Wendy A Leyden; Chun R Chao; Lanfang Xu; Charles P Quesenberry; Phyllis C Tien; Daniel B Klein; William J Towner; Michael A Horberg; Michael J Silverberg
Journal:  AIDS Patient Care STDS       Date:  2015-05-18       Impact factor: 5.078

2.  Immunological history governs human stem cell memory CD4 heterogeneity via the Wnt signaling pathway.

Authors:  Hassen Kared; Shu Wen Tan; Mai Chan Lau; Marion Chevrier; Crystal Tan; Wilson How; Glenn Wong; Marie Strickland; Benoit Malleret; Amanda Amoah; Karolina Pilipow; Veronica Zanon; Naomi Mc Govern; Josephine Lum; Jin Miao Chen; Bernett Lee; Maria Carolina Florian; Hartmut Geiger; Florent Ginhoux; Ezequiel Ruiz-Mateos; Tamas Fulop; Reena Rajasuriar; Adeeba Kamarulzaman; Tze Pin Ng; Enrico Lugli; Anis Larbi
Journal:  Nat Commun       Date:  2020-02-10       Impact factor: 14.919

3.  Cycling CD4+ T cells in HIV-infected immune nonresponders have mitochondrial dysfunction.

Authors:  Souheil-Antoine Younes; Aarthi Talla; Susan Pereira Ribeiro; Evgeniya V Saidakova; Larisa B Korolevskaya; Konstantin V Shmagel; Carey L Shive; Michael L Freeman; Soumya Panigrahi; Sophia Zweig; Robert Balderas; Leonid Margolis; Daniel C Douek; Donald D Anthony; Pushpa Pandiyan; Mark Cameron; Scott F Sieg; Leonard H Calabrese; Benigno Rodriguez; Michael M Lederman
Journal:  J Clin Invest       Date:  2018-10-15       Impact factor: 19.456

4.  A transcriptome-based model of central memory CD4 T cell death in HIV infection.

Authors:  Gustavo Olvera-García; Tania Aguilar-García; Fany Gutiérrez-Jasso; Iván Imaz-Rosshandler; Claudia Rangel-Escareño; Lorena Orozco; Irma Aguilar-Delfín; Joel A Vázquez-Pérez; Joaquín Zúñiga; Santiago Pérez-Patrigeon; Enrique Espinosa
Journal:  BMC Genomics       Date:  2016-11-22       Impact factor: 3.969

5.  Modelling CD4 T Cell Recovery in Hepatitis C and HIV Co-infected Children Receiving Antiretroviral Therapy.

Authors:  Adedeji O Majekodunmi; Claire Thorne; Ruslan Malyuta; Alla Volokha; Robin E Callard; Nigel J Klein; Joanna Lewis
Journal:  Pediatr Infect Dis J       Date:  2017-05       Impact factor: 2.129

6.  HCV coinfection contributes to HIV pathogenesis by increasing immune exhaustion in CD8 T-cells.

Authors:  Norma Rallón; Marcial García; Javier García-Samaniego; Noelia Rodríguez; Alfonso Cabello; Clara Restrepo; Beatriz Álvarez; Rosa García; Miguel Górgolas; José M Benito
Journal:  PLoS One       Date:  2017-03-21       Impact factor: 3.240

7.  Hepatic fibrosis and immune phenotype vary by HCV viremia in HCV/HIV co-infected subjects: A Women's interagency HIV study.

Authors:  Seema N Desai; Jennifer L Dodge; Alan L Landay; Marshall J Glesby; Patricia S Latham; Maria C Villacres; Audrey L French; Stephen J Gange; Ruth M Greenblatt; Marion G Peters
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

8.  Both HCV Infection and Elevated Liver Stiffness Significantly Impacts on Several Parameters of T-Cells Homeostasis in HIV-Infected Patients.

Authors:  Clara Restrepo; Beatriz Álvarez; José L Valencia; Marcial García; María A Navarrete-Muñoz; José M Ligos; Alfonso Cabello; Laura Prieto; Sara Nistal; María Montoya; Miguel Górgolas; Norma Rallón; José M Benito
Journal:  J Clin Med       Date:  2020-09-15       Impact factor: 4.241

9.  Systemic inflammation and liver damage in HIV/hepatitis C virus coinfection.

Authors:  K V Shmagel; E V Saidakova; N G Shmagel; L B Korolevskaya; V A Chereshnev; J Robinson; J-C Grivel; D C Douek; L Margolis; D D Anthony; M M Lederman
Journal:  HIV Med       Date:  2016-05-17       Impact factor: 3.094

10.  Evaluation of immunological indices in HIV-infected patients with chronic hepatitis C in Kazakhstan.

Authors:  Nazgul Sarsekeyeva; Bakhyt Kosherova
Journal:  Int J Gen Med       Date:  2016-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.